Researchers from Canada and Australia sought to assess the return on investment for Canada’s prison needle exchange programs, and the potential impact of scaling it up, as part of efforts to eliminate blood-borne infections in prisons. More

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study More

An article explores a hepatitis C testing program implemented at a remand prison, highlighting the role of oral swabs and peer involvement in increasing testing rates. More

The purpose of the guide is to support countries in developing policies that define a strategic mix of hepatitis B and C testing approaches, tailored to their unique situation ensuring an impactful national response to the hepatitis epidemic. More

In order for positive treatment outcomes to be sustained, HCV treatment programs must address the barriers patients face at multiple levels and implement system-level changes. More

People living with or at risk of hepatitis C virus, health care providers, and policymakers in low- and middle-income countries showed significant interest in a potential long-acting HCV cure, recent surveys have found. More

History has been made in Glasgow, Scotland, with the opening of The Thistle, the United Kingdom’s first Safer Drug Consumption Facility, on 13 January 2025. More

A Montreal study assigned patient navigators to 10 men released from prison with hepatitis C; Navigators’ knowledge and attitudes were more important to participants than lived experience. More